Okta (OKTA) 10-Q 3 Dec 24 2025 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Oct. 31, 2024	Nov. 29, 2024
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 31, 2024
Document Transition Report	false
Entity File Number	001-38044
Entity Registrant Name	Okta, Inc.
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	100 First Street, Suite 600
Entity Tax Identification Number	26-4175727
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94105
City Area Code	888
Local Phone Number	722-7871
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	OKTA
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Amendment Flag	false
Entity Central Index Key	0001660134
Current Fiscal Year End Date	--01-31
Document Fiscal Year Focus	2025
Document Period Focus	Q3
Class A
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		163,604,690
Class B
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		7,750,173

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Current assets:
Cash and cash equivalents	$ 310	$ 334
Short-term investments	1,938	1,868
Accounts receivable, net of allowances of $6 and $6, respectively	463	559
Deferred commissions	127	113
Prepaid expenses and other current assets	165	106
Total current assets	3,003	2,980
Property and equipment, net	46	48
Operating lease right-of-use assets	79	83
Deferred commissions, noncurrent	230	242
Intangible assets, net	151	182
Goodwill	5,448	5,406
Other assets	53	48
Total assets	9,010	8,989
Current liabilities:
Accounts payable	12	12
Accrued expenses and other current liabilities	151	115
Accrued compensation	147	167
Convertible senior notes, net	509	0
Deferred revenue	1,415	1,488
Total current liabilities	2,234	1,782
Convertible senior notes, net, noncurrent	349	1,154
Operating lease liabilities, noncurrent	102	112
Deferred revenue, noncurrent	25	23
Other liabilities, noncurrent	35	30
Total liabilities	2,745	3,101
Commitments and contingencies (Note 8)
Stockholders’ equity:
Preferred stock, par value $0.0001 per share; 100,000 shares authorized; no shares issued and outstanding as of October 31, 2024 and January 31, 2024	0	0
Additional paid-in capital	9,093	8,724
Accumulated other comprehensive loss	(3)	(6)
Accumulated deficit	(2,825)	(2,830)
Total stockholders’ equity	6,265	5,888
Total liabilities and stockholders' equity	9,010	8,989
Class A
Stockholders’ equity:
Common stock	0	0
Class B
Stockholders’ equity:
Common stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Allowance for accounts receivable	$ 6	$ 6
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	100,000,000	100,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Class A
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	163,602,000	159,835,000
Common stock, outstanding (in shares)	163,602,000	159,835,000
Class B
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	120,000,000	120,000,000
Common stock, issued (in shares)	7,750,000	7,291,000
Common stock, outstanding (in shares)	7,750,000	7,291,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue:
Total revenue	$ 665	$ 584	$ 1,928	$ 1,658
Cost of revenue:
Total cost of revenue	157	145	460	436
Gross profit	508	439	1,468	1,222
Operating expenses:
Research and development	158	165	485	500
Sales and marketing	256	270	730	787
General and administrative	110	111	335	340
Restructuring and other charges	0	4	0	28
Total operating expenses	524	550	1,550	1,655
Operating loss	(16)	(111)	(82)	(433)
Interest expense	(1)	(2)	(4)	(7)
Interest income and other, net	26	21	82	56
Gain on early extinguishment of debt	16	18	19	91
Interest and other, net	41	37	97	140
Income (loss) before provision for income taxes	25	(74)	15	(293)
Provision for income taxes	9	7	10	18
Net income (loss)	$ 16	$ (81)	$ 5	$ (311)
Net income (loss) per share, basic (in dollars per share)	$ 0.09	$ (0.49)	$ 0.03	$ (1.91)
Net income (loss) per share, diluted (in dollars per share)	$ 0	$ (0.49)	$ (0.08)	$ (1.91)
Weighted-average shares used to compute net income (loss) per share, basic (in shares)	170,217	164,381	168,775	162,836
Weighted-average shares used to compute net income (loss) per share, diluted (in shares)	170,673	164,381	169,768	162,836
Subscription
Revenue:
Total revenue	$ 651	$ 569	$ 1,886	$ 1,614
Cost of revenue:
Total cost of revenue	140	126	407	376
Professional services and other
Revenue:
Total revenue	14	15	42	44
Cost of revenue:
Total cost of revenue	$ 17	$ 19	$ 53	$ 60

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 16	$ (81)	$ 5	$ (311)
Other comprehensive income (loss):
Net change in unrealized gains or losses on available-for-sale securities	2	5	1	19
Foreign currency translation adjustments	2	(9)	2	(4)
Other comprehensive income (loss)	4	(4)	3	15
Comprehensive income (loss)	$ 20	$ (85)	$ 8	$ (296)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Millions	Total	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2023		154,009	7,300
Beginning balance at Jan. 31, 2023	$ 5,466	$ 0	$ 0	$ 7,974	$ (33)	$ (2,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,068
Issuance of common stock	8			8
Proceeds from hedges related to convertible senior notes (in shares)		(33)
Stock-based compensation	166			166
Other comprehensive income (loss)	13				13
Net income (loss)	(119)					(119)
Ending balance (in shares) at Apr. 30, 2023		155,044	7,300
Ending balance at Apr. 30, 2023	5,534	$ 0	$ 0	8,148	(20)	(2,594)
Beginning balance (in shares) at Jan. 31, 2023		154,009	7,300
Beginning balance at Jan. 31, 2023	5,466	$ 0	$ 0	7,974	(33)	(2,475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(311)
Ending balance (in shares) at Oct. 31, 2023		158,024	7,300
Ending balance at Oct. 31, 2023	5,730	$ 0	$ 0	8,534	(18)	(2,786)
Beginning balance (in shares) at Apr. 30, 2023		155,044	7,300
Beginning balance at Apr. 30, 2023	5,534	$ 0	$ 0	8,148	(20)	(2,594)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,696
Issuance of common stock	29			29
Stock-based compensation	186			186
Settlement of warrants	(4)			(4)
Other comprehensive income (loss)	6				6
Net income (loss)	(111)					(111)
Ending balance (in shares) at Jul. 31, 2023		156,740	7,300
Ending balance at Jul. 31, 2023	5,640	$ 0	$ 0	8,359	(14)	(2,705)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,284
Issuance of common stock	3			3
Stock-based compensation	175			175
Settlement of warrants	(3)			(3)
Other comprehensive income (loss)	(4)				(4)
Net income (loss)	(81)					(81)
Ending balance (in shares) at Oct. 31, 2023		158,024	7,300
Ending balance at Oct. 31, 2023	5,730	$ 0	$ 0	8,534	(18)	(2,786)
Beginning balance (in shares) at Jan. 31, 2024		159,835	7,291
Beginning balance at Jan. 31, 2024	5,888	$ 0	$ 0	8,724	(6)	(2,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,077
Issuance of common stock	6			6
Taxes withheld related to net share settlement of equity awards	(42)			(42)
Stock-based compensation	152			152
Other comprehensive income (loss)	(11)				(11)
Net income (loss)	(40)					(40)
Ending balance (in shares) at Apr. 30, 2024		160,912	7,291
Ending balance at Apr. 30, 2024	5,953	$ 0	$ 0	8,840	(17)	(2,870)
Beginning balance (in shares) at Jan. 31, 2024		159,835	7,291
Beginning balance at Jan. 31, 2024	5,888	$ 0	$ 0	8,724	(6)	(2,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5
Ending balance (in shares) at Oct. 31, 2024		163,602	7,750
Ending balance at Oct. 31, 2024	6,265	$ 0	$ 0	9,093	(3)	(2,825)
Beginning balance (in shares) at Apr. 30, 2024		160,912	7,291
Beginning balance at Apr. 30, 2024	5,953	$ 0	$ 0	8,840	(17)	(2,870)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,470	172
Issuance of common stock	31			31
Taxes withheld related to net share settlement of equity awards	(40)			(40)
Conversion of Class B common stock to Class A common stock (in shares)		15	(15)
Stock-based compensation	150			150
Other comprehensive income (loss)	10				10
Net income (loss)	29					29
Ending balance (in shares) at Jul. 31, 2024		162,397	7,448
Ending balance at Jul. 31, 2024	6,133	$ 0	$ 0	8,981	(7)	(2,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		1,205	302
Issuance of common stock	9			9
Taxes withheld related to net share settlement of equity awards	(32)			(32)
Stock-based compensation	135			135
Other comprehensive income (loss)	4				4
Net income (loss)	16					16
Ending balance (in shares) at Oct. 31, 2024		163,602	7,750
Ending balance at Oct. 31, 2024	$ 6,265	$ 0	$ 0	$ 9,093	$ (3)	$ (2,825)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 5	$ (311)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation	434	523
Depreciation, amortization and accretion	64	64
Amortization of deferred commissions	95	76
Deferred income taxes	(2)	4
Lease impairment charges	0	25
Gain on early extinguishment of debt	(19)	(91)
Other, net	8	9
Changes in operating assets and liabilities:
Accounts receivable	94	61
Deferred commissions	(97)	(102)
Prepaid expenses and other assets	(60)	(1)
Operating lease right-of-use assets	16	18
Accounts payable	(1)	(1)
Accrued compensation	(21)	70
Accrued expenses and other liabilities	44	9
Operating lease liabilities	(26)	(29)
Deferred revenue	(70)	14
Net cash provided by operating activities	464	338
Cash flows from investing activities:
Capitalized software	(11)	(10)
Purchases of property and equipment	(7)	(5)
Purchases of securities available-for-sale and other	(1,253)	(1,151)
Proceeds from maturities and redemption of securities available-for-sale	1,187	1,702
Proceeds from sales of securities available-for-sale and other	3	61
Purchases of intangible assets	0	(1)
Payments for business acquisitions, net of cash acquired	(56)	(22)
Net cash provided by (used in) investing activities	(137)	574
Cash flows from financing activities:
Payments for repurchases of convertible senior notes	(280)	(803)
Taxes paid related to net share settlement of equity awards	(113)	0
Payments for warrants related to convertible senior notes	0	(7)
Proceeds from stock option exercises	17	10
Proceeds from shares issued in connection with employee stock purchase plan	24	26
Net cash used in financing activities	(352)	(774)
Effects of changes in foreign currency exchange rates on cash, cash equivalents and restricted cash	1	(1)
Net increase (decrease) in cash, cash equivalents and restricted cash	(24)	137
Cash, cash equivalents and restricted cash at beginning of period	342	271
Cash, cash equivalents and restricted cash at end of period	318	408
Cash paid during the period for:
Operating leases	31	34
Non-cash activities:
Benefit from exercise of hedges related to convertible senior notes	0	2
Operating lease right-of-use assets exchanged for lease liabilities	9	11
Reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:
Cash and cash equivalents	310	400
Restricted cash, current included in prepaid expenses and other current assets	2	2
Restricted cash, noncurrent included in other assets	6	6
Total cash, cash equivalents and restricted cash	$ 318	$ 408

Overview and Basis of Presentat

Overview and Basis of Presentation	9 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of Business Okta, Inc. (the “Company”) is the leading independent identity partner. The Company’s Workforce Identity Cloud and Customer Identity Cloud, powered by Auth0, enable customers to securely connect the right people to the right technologies and services at the right time. Employees and contractors sign into the Workforce Identity Cloud to seamlessly and securely access the applications they need to do their most important work. Organizations use the Company’s Identity Platform to collaborate with their partners, and to provide their customers with more modern and secure experiences in the cloud and via mobile devices. Developers leverage the Workforce Identity Cloud and Customer Identity Cloud to securely and efficiently embed identity into the software they build, allowing them to innovate and focus on their core missions. The Company is headquartered in San Francisco, California. Basis of Presentation and Principles of Consolidation The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements. All intercompany balances and transactions have been eliminated in consolidation. The Company conducts business globally and is managed, operated and organized by major functional departments that operate on a consolidated basis. As a result, the Company operates in one reportable segment. The condensed consolidated balance sheet as of January 31, 2024, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2025 or any future period. The Company’s fiscal year ends on January 31. References to fiscal 2025, for example, refer to the fiscal year ending January 31, 2025. Certain prior period amounts have been reclassified to conform to the current period presentation. The condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 1, 2024. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience and on other assumptions that management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the valuation of deferred income tax assets, uncertain tax positions, assets and liabilities acquired in business combinations, and loss contingencies related to litigation.

Accounting Standards and Signif

Accounting Standards and Significant Accounting Policies	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Accounting Standards and Significant Accounting Policies	Accounting Standards and Significant Accounting Policies Significant Accounting Policies For a summary of the Company’s significant accounting policies refer to “Note 2. Summary of Significant Accounting Policies” of its Annual Report on Form 10-K for the fiscal year ended January 31, 2024. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued guidance which requires disclosure of incremental segment information on an annual and interim basis. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company plans to adopt this guidance in fiscal 2025 and does not expect a material impact to its consolidated financial statements. In December 2023, the FASB issued guidance to provide disaggregated income tax disclosures on the rate reconciliation and income taxes paid. This guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company intends to adopt this guidance in fiscal 2026 and expects the adoption of the updated guidance to result in disclosure of additional disaggregated tax information. In November 2024, the FASB issued guidance requiring the disclosure, in the notes to financial statements, of specified disaggregated income statement expense information. This guidance is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of this guidance.

Restructuring and Other Charges

Restructuring and Other Charges	9 Months Ended
	Oct. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Restructuring and Other Charges During the fourth quarter of fiscal 2024, the Company approved a restructuring plan (the “2024 Restructuring Plan”) intended to improve operating efficiencies and profitability. The 2024 Restructuring Plan involved a reduction of the Company’s workforce by approximately 400 full-time employees. The 2024 Restructuring Plan was substantially complete by the first quarter of fiscal 2025 and the Company recognized aggregate restructuring costs of $24 million in the fourth quarter of fiscal 2024. The following table summarizes the Company’s restructuring liability related to the 2024 Restructuring Plan that is included in Accrued expenses and other current liabilities on the condensed consolidated balance sheets: Severance and termination benefit costs (dollars in millions) Balance as of January 31, 2024 $ 24 Restructuring charges — Cash payments (24) Balance as of October 31, 2024 $ —

Cash Equivalents and Investment

Cash Equivalents and Investments	9 Months Ended
	Oct. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Investments	Cash Equivalents and Investments Cash Equivalents and Short-term Investments In estimating fair value, the Company uses a three-tier fair value hierarchy as follows: • Level 1 — Valuations based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets. • Level 2 — Valuations based on other inputs that are directly or indirectly observable in the marketplace. • Level 3 — Valuations based on unobservable inputs that are supported by little or no market activity. The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of October 31, 2024 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Cash equivalents: Money market funds (Level 1) $ 162 $ — $ — $ 162 Certificates of deposit (Level 2) 23 — — 23 Total cash equivalents 185 — — 185 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,646 3 (1) 1,648 Corporate debt securities 254 1 — 255 Certificates of deposit 35 — — 35 Total short-term investments 1,935 4 (1) 1,938 Total $ 2,120 $ 4 $ (1) $ 2,123 As of January 31, 2024 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 151 $ — $ — $ 151 Total cash equivalents 151 — — 151 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,782 3 (1) 1,784 Corporate debt securities 43 — — 43 Certificates of deposit 41 — — 41 Total short-term investments 1,866 3 (1) 1,868 Total $ 2,017 $ 3 $ (1) $ 2,019 The following table presents the contractual maturities of the Company’s short-term investments: As of October 31, 2024 Amortized Cost Estimated Fair Value (dollars in millions) Due within one year $ 1,422 $ 1,424 Due between one to five years 513 514 Total $ 1,935 $ 1,938 Interest receivable of $22 million and $20 million is included in Prepaid expenses and other current assets on the condensed consolidated balance sheets as of October 31, 2024 and January 31, 2024, respectively. The Company had 33 and 41 short-term investments in unrealized loss positions as of October 31, 2024 and January 31, 2024, respectively. For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) the Company has the intention to sell any of these investments, (ii) it is not more likely than not that the Company will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis and (iii) the decline in the fair value of the investment is due to credit or non-credit related factors. There were no material credit or non-credit related impairments for short-term investments as of October 31, 2024 and January 31, 2024. Strategic Investments Strategic investments primarily include equity investments in privately-held companies, which do not have a readily determinable fair value. As of October 31, 2024 and January 31, 2024, the balance of strategic investments was $31 million and $26 million, respectively.

Deferred Commissions

Deferred Commissions	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred Commissions	Deferred Commissions Sales commissions capitalized as contract costs totaled $37 million in each of the three months ended October 31, 2024 and 2023, and $97 million and $102 million for the nine months ended October 31, 2024 and 2023, respectively. Amortization of contract costs totaled $33 million and $27 million for the three months ended October 31, 2024 and 2023, respectively, and $95 million and $76 million for the nine months ended October 31, 2024 and 2023, respectively. Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended October 31, 2024 and 2023 that was included in the deferred revenue balances at the beginning of the respective periods was $597 million and $519 million, respectively, and $1,312 million and $1,114 million in the nine months ended October 31, 2024 and 2023, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. Total remaining non-cancelable performance obligations under subscription contracts with customers was approximately $3,659 million as of October 31, 2024 . Of this amount, the Company expects to recognize revenue of approximately $2,062 million, or 56%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2024 were not material.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	9 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Commissions Sales commissions capitalized as contract costs totaled $37 million in each of the three months ended October 31, 2024 and 2023, and $97 million and $102 million for the nine months ended October 31, 2024 and 2023, respectively. Amortization of contract costs totaled $33 million and $27 million for the three months ended October 31, 2024 and 2023, respectively, and $95 million and $76 million for the nine months ended October 31, 2024 and 2023, respectively. Deferred Revenue Deferred revenue, which is a contract liability, consists primarily of payments received and accounts receivable recorded in advance of revenue recognition under the Company’s contracts with customers and is recognized as the revenue recognition criteria are met. Subscription revenue recognized during the three months ended October 31, 2024 and 2023 that was included in the deferred revenue balances at the beginning of the respective periods was $597 million and $519 million, respectively, and $1,312 million and $1,114 million in the nine months ended October 31, 2024 and 2023, respectively. Transaction Price Allocated to the Remaining Performance Obligations Transaction price allocated to the remaining performance obligations (“RPO”) represents all future, non-cancelable contracted revenue that has not yet been recognized, inclusive of deferred revenue that has been invoiced and non-cancelable amounts that will be invoiced and recognized as revenue in future periods. Total remaining non-cancelable performance obligations under subscription contracts with customers was approximately $3,659 million as of October 31, 2024 . Of this amount, the Company expects to recognize revenue of approximately $2,062 million, or 56%, over the next 12 months, with the balance to be recognized as revenue thereafter. Remaining performance obligations for professional services and other contracts as of October 31, 2024 were not material.

Convertible Senior Notes, Net

Convertible Senior Notes, Net	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes, Net	Convertible Senior Notes, Net Convertible Senior Notes The 2025 convertible senior notes (“2025 Notes”) and the 2026 convertible senior notes (“2026 Notes” and together with the 2025 Notes, the “Notes”) are recorded at face value less unamortized debt issuance costs. As of October 31, 2024, the 2025 Notes are classified as current liabilities due to their upcoming maturity on September 1, 2025. During the three months ended October 31, 2024, the Company repurchased $42 million principal amount of the 2025 Notes for $40 million in cash, and $215 million principal amount of the 2026 Notes for $200 million in cash, resulting in a gain on early extinguishment of debt of $16 million. During the nine months ended October 31, 2024, the Company repurchased $42 million principal amount of the 2025 Notes for $40 million in cash, and $258 million principal amount of the 2026 Notes for $240 million in cash, resulting in a gain on early extinguishment of debt of $19 million. During the three months ended October 31, 2023, the Company repurchased $150 million principal amount of the 2026 Notes for $132 million in cash, resulting in a gain on early extinguishment of debt of $18 million. During the nine months ended October 31, 2023, the Company repurchased $508 million principal amount of the 2025 Notes for $462 million in cash, and $392 million principal amount of the 2026 Notes for $341 million in cash, resulting in a gain on early extinguishment of debt of $91 million. The net carrying amount of the Notes consisted of the following: As of October 31, 2024 As of January 31, 2024 (dollars in millions) 2025 Notes: Principal $ 510 $ 552 Less: unamortized debt issuance costs (1) (3) Net carrying amount $ 509 $ 549 2026 Notes: Principal $ 350 $ 608 Less: unamortized debt issuance costs (1) (3) Net carrying amount $ 349 $ 605 Fair Value Measurements The following table presents the principal amounts and estimated fair values of the Notes, which are not recorded at fair value on the condensed consolidated balance sheets: As of October 31, 2024 Principal Amount Estimated Fair Value (dollars in millions) 2025 Notes $ 510 $ 486 2026 Notes $ 350 $ 324 The estimated fair values of the Notes, which are Level 2 financial instruments, were determined based on the quoted bid prices of the Notes in an over-the-counter market on the last trading day of the reporting period.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Letters of Credit In conjunction with the execution of certain office space operating leases, letters of credit in the aggregate amount of $7 million were issued and outstanding as of October 31, 2024 and January 31, 2024. No draws have been made under such letters of credit. Legal Matters From time to time in the normal course of business, the Company may be subject to various legal matters such as threatened or pending claims or proceedings. On May 20, 2022, a purported shareholder filed a putative class action lawsuit in the United States District Court for the Northern District of California against the Company and certain of its executive officers, captioned In re Okta, Inc. Securities Litigation , No. 3:22-cv-02990. The lawsuit asserted claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, alleging that the defendants made false or misleading statements or omissions concerning the Company’s cybersecurity controls, vulnerability to data breaches, and the Company’s integration of Auth0, Inc. (“Auth0”). The lawsuit sought an order certifying the lawsuit as a class action and unspecified damages. The defendants moved to dismiss the amended complaint. On March 31, 2023, the court issued an order granting in part and denying in part the motion to dismiss. The court dismissed in full the claims based on the plaintiff’s allegations related to the Company’s cybersecurity controls and vulnerability to data breaches, and dismissed in part and denied in part the claims based on allegations related to the Auth0 integration. On February 5, 2024, the court granted the plaintiffs’ unopposed motion for class certification. On May 28, 2024, the parties entered into a stipulation of settlement, subject to court approval (the “Stipulation”). Under the terms of the Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants, the Company agreed to pay and/or to cause its insurance carriers to pay a total of $60 million, which is covered through a combination of the Company’s Director & Officer ("D&O") insurance and the balance of the Company’s $10 million retention on the primary D&O policy. The Stipulation does not constitute an admission of fault or wrongdoing by the Company or its executives. On July 19, 2024, the court granted preliminary approval of the Stipulation, ordered that notice be disseminated to the settlement class, and set a final settlement approval hearing for November 8, 2024. On November 19, 2024, the court granted final approval of the Stipulation. The Company recognized a liability, which is included in Accrued expenses and other current liabilities on its condensed consolidated balance sheets in the amount of $60 million which represents the Company's gross obligation to settle claims under the Stipulation. A corresponding receivable was recognized, which is included in Prepaid expenses and other current assets on the Company’s condensed consolidated balance sheets, which represents the insurance proceeds the Company is entitled to under its D&O insurance policies that will be paid by the Company’s insurers to settle claims on its behalf. Additionally, two purported shareholders filed derivative lawsuits on behalf of the Company in the United States District Court for the Northern District of California against certain of its current and former executive officers and directors, captioned O’Dell v. McKinnon et al. , No. 3:22-cv-07480 (filed Nov. 28, 2022), and LR Trust v. McKinnon et al ., No. 3:22-cv-08627 (filed Dec. 13, 2022). The lawsuits allege, among other things, that the defendants breached their fiduciary duties by making false or misleading statements or omissions concerning the Company’s cybersecurity controls, vulnerability to data breaches, and the Company’s integration of Auth0. The lawsuits seek orders permitting the plaintiffs to maintain the actions derivatively on behalf of the Company, awarding unspecified damages allegedly sustained by the Company, awarding restitution from the individual defendants, and requiring the Company to make certain reforms to its corporate governance and controls. On February 22, 2023, the court entered a stipulated order consolidating the derivative actions, appointing co-lead counsel for plaintiffs, and staying the consolidated derivative actions during the pendency of the motion to dismiss in the securities class action lawsuit. The consolidated derivative action is captioned In re Okta, Inc. Stockholder Derivative Litigation , No. 3:22-cv-07480. On May 9, 2023, the court entered a stipulated order continuing the stay through the close of discovery in the securities class action lawsuit. On April 14, 2023, another shareholder filed a substantially similar derivative lawsuit in the United States District Court for the District of Delaware against certain of the Company’s current and former executive officers and directors, captioned Buono v. McKinnon et al. , No. 1:23-cv-00413. On May 31, 2023, the court entered a stipulated order whereby the defendants agreed to accept service and stay the derivative action through the close of discovery in the securities class action lawsuit. On January 25, 2024, another shareholder filed a substantially similar derivative lawsuit in the United States District Court for the District of Delaware against certain of the Company’s current and former executive officers and directors, captioned Nasr v. McKinnon, et al. , No. 1:24-cv-00106. On March 18, 2024, the court entered a stipulated order whereby the defendants agreed to accept service and stay the derivative action through the close of discovery in the securities class action lawsuit. On July 1, 2024, another shareholder filed a substantially similar derivative lawsuit in the Court of Chancery for the State of Delaware (the “Delaware Chancery Court”) against certain of the Company’s current and former executive officers and directors, captioned Grimaldi v. McKinnon, et al. , C.A. No. 2024-0685-PAF (the “Grimaldi Action”). On July 19, 2024, the Delaware Chancery Court entered a stipulated order whereby the defendants agreed to accept service and to stay the derivative action through final approval of the settlement in the securities class action lawsuit. On October 18, 2024, another shareholder filed a substantially similar derivative lawsuit in the Delaware Chancery Court against certain of the Company’s current and former executive officers and directors, captioned Duprat v. McKinnon, et al ., C.A. No. 2024-1072-PAF (the “Duprat Action”). On November 8, 2024, the Delaware Chancery Court entered a stipulated order where the defendants agreed to accept service in the Duprat Action, the Grimaldi Action and the Duprat Action were consolidated, and the consolidated action was stayed pursuant to the terms previously entered in the Grimaldi Action. While the Company and defendants have agreed to settle the securities class action litigation, due to the stage of the related derivative lawsuits, the Company is unable to predict the outcome or estimate the amount of loss or range of losses that could potentially result from these lawsuits. Warranties and Indemnification To date, the Company has not incurred significant costs and has not accrued any material liabilities in the accompanying condensed consolidated financial statements as a result of its warranty and indemnification obligations.

Employee Incentive Plans

Employee Incentive Plans	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Employee Incentive Plans	Employee Incentive Plans The Company’s equity incentive plans provide for granting stock options, restricted stock units (“RSUs”), restricted stock awards (“RSAs”) to employees, consultants, officers and directors and RSUs with market-based vesting conditions to certain executives. In addition, the Company offers an Employee Stock Purchase Plan (“ESPP”) to eligible employees. Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (dollars in millions) Cost of revenue Subscription $ 20 $ 20 $ 61 $ 57 Professional services and other 3 3 9 11 Research and development 49 70 168 212 Sales and marketing 33 40 99 119 General and administrative 30 39 97 124 Total $ 135 $ 172 $ 434 $ 523 The following table presents total unrecognized stock-based compensation expense related to outstanding equity awards as of October 31, 2024: Unrecognized Stock-based Compensation Expense Weighted-average remaining period Unvested RSUs $ 813 2.0 years Unvested RSAs 16 2.4 years Unvested stock options 2 0.3 years ESPP 13 0.6 years Total $ 844 During the first quarter of fiscal 2025, the Company began funding withholding taxes due upon the vesting of employee RSUs in certain jurisdictions by net share settlement, rather than its previous approach of selling shares of the Company’s common stock. The amount of withholding taxes related to net share settlement of employee RSUs is reflected as (i) a reduction to additional paid-in-capital, and (ii) cash outflows for financing activities when the payments are made. The shares withheld by the Company as a result of the net share settlement of RSUs are not considered issued and outstanding, and do not impact the calculation of basic net income (loss) per share attributable to the Class A and Class B common stockholders. Market-based Restricted Stock Units In March 2024, the Company granted market-based RSUs to certain members of management. The target number of market-based RSUs granted was 183,595. One-third of these market-based RSUs vest over each of a one-, two- and three-year performance period, each starting on February 1, 2024. The number of shares that can be earned ranges from 0% to 200% of the target number of shares based on the relative performance of the per share price of the Company’s common stock as compared to the Nasdaq Composite Index over the respective performance periods and subject to continuous employment through the vesting dates. The $182.15 average grant date fair value per target market-based RSU was determined using a Monte Carlo simulation approach. Compensation expense for awards with market conditions is recognized over the service period using the accelerated attribution method and is not reversed if the market condition is not met.

Income Taxes

Income Taxes	9 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and nine months ended October 31, 2024, the Company recorded a provision for income taxes of $9 million and $10 million on pretax income of $25 million and $15 million, respectively. The effective tax rate for the three and nine months ended October 31, 2024 was approximately 40.4% and 69.6%, respectively. The effective tax rate differs from the statutory rate primarily as a result of a full valuation allowance against the U.S. deferred tax assets, the tax effect of foreign operations, the tax impacts of the Spera Cybersecurity, Inc. and its subsidiary (collectively, “Spera”) integration, and U.S. federal and state taxes. For the three and nine months ended October 31, 2023, the Company recorded a tax provision of $7 million and $18 million on pretax losses of $74 million and $293 million, respectively. The effective tax rate for the three and nine months ended October 31, 2023 was approximately (9.0)% and (6.0)%, respectively. The effective tax rate differs from the statutory rate primarily as a result of a full valuation allowance against the U.S. deferred tax assets, the tax effect of foreign operations, U.S. federal and state taxes, and shortfalls from stock-based compensation. The Tax Cuts and Jobs Act enacted on December 22, 2017 amended Internal Revenue Code Section 174 to require that specific research and experimental ("R&E") expenditures be capitalized and amortized over five years (U.S. R&E) or fifteen years (non-U.S. R&E) beginning in the Company's fiscal 2023. As a result, the Company has been utilizing its federal and state tax attributes and incurring cash taxes due to this provision since fiscal 2023.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	Net Income (Loss) Per Share The Company computes net income (loss) per share of common stock in conformity with the two-class method required for participating securities. The dilutive effect of potentially dilutive common shares included in diluted earnings per share is determined in accordance with the treasury stock, if-converted, or contingently issuable accounting methods, depending on the nature of the security. The following table presents the calculation of basic and diluted net income (loss) per share. Net income (loss) is reported in millions and rounded from amounts in thousands; as a result, net income (loss) per share may not recalculate exactly due to rounding. Three Months Ended 2024 2023 Class A Class B Total Class A Class B Total (dollars in millions, shares in thousands, except per share data) Basic net income (loss) per share: Numerator: Net income (loss), basic $ 15 $ 1 $ 16 $ (77) $ (4) $ (81) Denominator: Weighted-average shares outstanding, basic 162,681 7,536 170,217 157,081 7,300 164,381 Net income (loss) per share, basic $ 0.09 $ 0.09 $ 0.09 $ (0.49) $ (0.49) $ (0.49) Diluted net income (loss) per share: Numerator: Net income (loss) $ 15 $ 1 $ 16 $ (77) $ (4) $ (81) Gain on extinguishment of debt, net of interest expense 1 (15) (1) (16) — — $ — Net income (loss), diluted $ — $ — $ — $ (77) $ (4) $ (81) Denominator: Number of shares used in basic calculation 162,681 7,536 170,217 157,081 7,300 164,381 Weighted-average effect of diluted securities related to: Convertible senior notes 456 — 456 — — — Number of shares used in diluted calculation 163,137 7,536 170,673 157,081 7,300 164,381 Net income (loss) per share, diluted $ 0.00 $ 0.00 $ 0.00 $ (0.49) $ (0.49) $ (0.49) 1 Under the if-converted method, net income is adjusted to reflect the assumption that the convertible senior notes were converted at the beginning of the period. Nine Months Ended 2024 2023 Class A Class B Total Class A Class B Total (dollars in millions, shares in thousands, except per share data) Basic net income (loss) per share: Numerator: Net income (loss), basic $ 5 $ — $ 5 $ (297) $ (14) $ (311) Denominator: Weighted-average shares outstanding, basic 161,398 7,377 168,775 155,536 7,300 162,836 Net income (loss) per share, basic $ 0.03 $ 0.03 $ 0.03 $ (1.91) $ (1.91) $ (1.91) Diluted net income (loss) per share: Numerator: Net income (loss) $ 5 $ — $ 5 $ (297) $ (14) $ (311) Gain on extinguishment of debt, net of interest expense 1 (17) (1) (18) — — $ — Net income (loss), diluted $ (12) $ (1) $ (13) $ (297) $ (14) $ (311) Denominator: Number of shares used in basic calculation 161,398 7,377 168,775 155,536 7,300 162,836 Weighted-average effect of diluted securities related to: Convertible senior notes 993 — 993 — — — Number of shares used in diluted calculation 162,391 7,377 169,768 155,536 7,300 162,836 Net income (loss) per share, diluted $ (0.08) $ (0.08) $ (0.08) $ (1.91) $ (1.91) $ (1.91) 1 Under the if-converted method, net income is adjusted to reflect the assumption that the convertible senior notes were converted at the beginning of the period. Potentially dilutive securities excluded because they would be anti-dilutive were as follows: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (shares in thousands) Employee share-based awards 13,444 16,731 13,444 16,731 Convertible senior notes 4,170 6,102 4,170 6,102 Total 17,614 22,833 17,614 22,833 The Company entered into capped call transactions in connection with the issuance of the convertible senior notes. The effect of the capped calls was also excluded from the calculation of diluted net income per share as the effect of the capped calls would have been anti-dilutive.

Business Combinations

Business Combinations	9 Months Ended
	Oct. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combinations	Business Combinations On February 1, 2024, the Company acquired all of the outstanding equity of Spera, an identity security platform provider. The acquisition of Spera is expected to broaden the Company's identity threat detection and security posture management capabilities. The Spera acquisition was accounted for as a business combination. The acquisition date fair value of purchase consideration transferred for Spera of $58 million was paid in cash. Of this amount, $12 million of consideration was transferred to an escrow fund as partial security for any purchase price adjustments and indemnification obligations, and will be paid to the former Spera stockholders following the 18-month anniversary of the closing date (less any such adjustments or indemnification obligations). The Company preliminarily recorded $18 million for developed technology intangible assets with an estimated useful life of 5 years and preliminarily recorded $42 million of goodwill which is primarily attributed to the assembled workforce as well as the integration of Spera’s technology and the Company’s technology. None of the goodwill is expected to be deductible for U.S. federal income tax purposes. The Company may continue to adjust the preliminary purchase price allocation after obtaining more information primarily relating to income based taxes and residual goodwill through the measurement period, no more than one year from the date of acquisition. The Company entered into revesting agreements with Spera’s founders pursuant to which 238,795 additional shares of Okta’s Class A common stock were issued as of the closing date which vest over three years. The $20 million fair value of the unvested restricted stock award is attributable to a post-combination service condition and will be accounted for by the Company separately from the business combination as stock-based compensation expense. Acquisition related expenses incurred were not material. This acquisition did not have a material impact on the Company’s condensed consolidated financial statements; therefore, historical and pro forma disclosures have not been presented.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 16	$ 29	$ (40)	$ (81)	$ (111)	$ (119)	$ 5	$ (311)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Oct. 31, 2024 shares	Oct. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
J. Frederic Kerrest [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 19, 2024, J. Frederic Kerrest, Vice Chairperson of our board of directors, adopted a Rule 10b5-1 trading arrangement (the “Kerrest 10b5-1 Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act (“Rule 10b5-1(c)”). The Kerrest 10b5-1 Plan provides for the sale, commencing on January 20, 2025 and continuing until all shares are sold or until June 30, 2025, whichever occurs first, of (A) any shares that remain unsold under a prior Rule 10b5-1 trading arrangement adopted on March 6, 2024; (B) up to 988,852 shares of our Class A common stock upon exercise of expiring stock options; (C) 151,622 shares of our Class A common stock; and (D) an indeterminable amount of shares acquired upon the future vesting of RSUs.
Name	J. Frederic Kerrest
Title	Vice Chairperson of our board of directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 19, 2024
Expiration Date	June 30, 2025
Arrangement Duration	161 days
Brett Tighe [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On October 11, 2024, Brett Tighe, Chief Financial Officer of the Company, adopted a Rule 10b5-1 trading arrangement (the “Tighe 10b5-1 Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The Tighe 10b5-1 Plan provides for the sale of up to 20,000 shares of our Class A common stock, commencing on January 21, 2025 and continuing until all shares are sold or until April 11, 2025, whichever occurs first.
Name	Brett Tighe
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	October 11, 2024
Expiration Date	April 11, 2025
Arrangement Duration	80 days
Aggregate Available	20,000	20,000
Larissa Schwartz [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 30, 2024, Larissa Schwartz, Chief Legal Officer and Corporate Secretary of the Company, adopted a Rule 10b5-1 trading arrangement (the “Schwartz 10b5-1 Plan”) that is intended to satisfy the affirmative defense of Rule 10b5-1(c). The Schwartz 10b5-1 Plan provides for the sale of up to 14,167 shares of our Class A common stock, plus an indeterminable amount of shares acquired upon the future vesting of RSUs, commencing on December 30, 2024 and continuing until all shares are sold or until September 30, 2025, whichever occurs first.
Name	Larissa Schwartz
Title	Chief Legal Officer and Corporate Secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 30, 2024
Expiration Date	September 30, 2025
Arrangement Duration	274 days
Aggregate Available	14,167	14,167
J. Frederic Kerrest Trading Arrangement, Stock Options [Member] | J. Frederic Kerrest [Member]
Trading Arrangements, by Individual
Aggregate Available	988,852	988,852
J. Frederic Kerrest Trading Arrangement, Common Stock [Member] | J. Frederic Kerrest [Member]
Trading Arrangements, by Individual
Aggregate Available	151,622	151,622

Accounting Standards and Sign_2

Accounting Standards and Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim periods. Accordingly, they do not include all of the financial information and footnotes required by GAAP for complete financial statements.
Principles of Consolidation	All intercompany balances and transactions have been eliminated in consolidation. The Company conducts business globally and is managed, operated and organized by major functional departments that operate on a consolidated basis. As a result, the Company operates in one reportable segment. The condensed consolidated balance sheet as of January 31, 2024, included herein, was derived from the audited financial statements as of that date. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for a fair statement of the results of operations for the interim periods presented but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year ending January 31, 2025 or any future period.
Fiscal Period	The Company’s fiscal year ends on January 31. References to fiscal 2025, for example, refer to the fiscal year ending January 31, 2025.
Reclassifications	Certain prior period amounts have been reclassified to conform to the current period presentation.
Use of Estimates	The preparation of condensed consolidated financial statements in conformity with GAAP requires estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are based on historical experience and on other assumptions that management believes are reasonable under the circumstances. Actual results could vary from those estimates. The Company’s most significant estimates include the valuation of deferred income tax assets, uncertain tax positions, assets and liabilities acquired in business combinations, and loss contingencies related to litigation.
Recent Accounting Pronouncements Not Yet Adopted	In November 2023, the Financial Accounting Standards Board (“FASB”) issued guidance which requires disclosure of incremental segment information on an annual and interim basis. This guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company plans to adopt this guidance in fiscal 2025 and does not expect a material impact to its consolidated financial statements. In December 2023, the FASB issued guidance to provide disaggregated income tax disclosures on the rate reconciliation and income taxes paid. This guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company intends to adopt this guidance in fiscal 2026 and expects the adoption of the updated guidance to result in disclosure of additional disaggregated tax information. In November 2024, the FASB issued guidance requiring the disclosure, in the notes to financial statements, of specified disaggregated income statement expense information. This guidance is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of this guidance.

Restructuring and Other Charg_2

Restructuring and Other Charges (Tables)	9 Months Ended
	Oct. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve	The following table summarizes the Company’s restructuring liability related to the 2024 Restructuring Plan that is included in Accrued expenses and other current liabilities on the condensed consolidated balance sheets: Severance and termination benefit costs (dollars in millions) Balance as of January 31, 2024 $ 24 Restructuring charges — Cash payments (24) Balance as of October 31, 2024 $ —

Cash Equivalents and Investme_2

Cash Equivalents and Investments (Tables)	9 Months Ended
	Oct. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments	The following tables present the amortized cost, unrealized gain (loss) and estimated fair value of cash equivalents and short-term investments: As of October 31, 2024 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Cash equivalents: Money market funds (Level 1) $ 162 $ — $ — $ 162 Certificates of deposit (Level 2) 23 — — 23 Total cash equivalents 185 — — 185 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,646 3 (1) 1,648 Corporate debt securities 254 1 — 255 Certificates of deposit 35 — — 35 Total short-term investments 1,935 4 (1) 1,938 Total $ 2,120 $ 4 $ (1) $ 2,123 As of January 31, 2024 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value (dollars in millions) Level 1: Cash equivalents: Money market funds $ 151 $ — $ — $ 151 Total cash equivalents 151 — — 151 Level 2: Short-term investments (Available-for-sale): U.S. treasury securities 1,782 3 (1) 1,784 Corporate debt securities 43 — — 43 Certificates of deposit 41 — — 41 Total short-term investments 1,866 3 (1) 1,868 Total $ 2,017 $ 3 $ (1) $ 2,019
Schedule of Contractual Maturities of Short-term Investments	The following table presents the contractual maturities of the Company’s short-term investments: As of October 31, 2024 Amortized Cost Estimated Fair Value (dollars in millions) Due within one year $ 1,422 $ 1,424 Due between one to five years 513 514 Total $ 1,935 $ 1,938

Convertible Senior Notes, Net (

Convertible Senior Notes, Net (Tables)	9 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	The net carrying amount of the Notes consisted of the following: As of October 31, 2024 As of January 31, 2024 (dollars in millions) 2025 Notes: Principal $ 510 $ 552 Less: unamortized debt issuance costs (1) (3) Net carrying amount $ 509 $ 549 2026 Notes: Principal $ 350 $ 608 Less: unamortized debt issuance costs (1) (3) Net carrying amount $ 349 $ 605
Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note	The following table presents the principal amounts and estimated fair values of the Notes, which are not recorded at fair value on the condensed consolidated balance sheets: As of October 31, 2024 Principal Amount Estimated Fair Value (dollars in millions) 2025 Notes $ 510 $ 486 2026 Notes $ 350 $ 324

Employee Incentive Plans (Table

Employee Incentive Plans (Tables)	9 Months Ended
	Oct. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense by Statement of Operations Location	Stock-based compensation expense was recorded in the following cost and expense categories in the Company’s condensed consolidated statements of operations: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (dollars in millions) Cost of revenue Subscription $ 20 $ 20 $ 61 $ 57 Professional services and other 3 3 9 11 Research and development 49 70 168 212 Sales and marketing 33 40 99 119 General and administrative 30 39 97 124 Total $ 135 $ 172 $ 434 $ 523
Schedule of Unrecognized Stock-based Compensation Expense	The following table presents total unrecognized stock-based compensation expense related to outstanding equity awards as of October 31, 2024: Unrecognized Stock-based Compensation Expense Weighted-average remaining period Unvested RSUs $ 813 2.0 years Unvested RSAs 16 2.4 years Unvested stock options 2 0.3 years ESPP 13 0.6 years Total $ 844

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	9 Months Ended
	Oct. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net income (loss) per share. Net income (loss) is reported in millions and rounded from amounts in thousands; as a result, net income (loss) per share may not recalculate exactly due to rounding. Three Months Ended 2024 2023 Class A Class B Total Class A Class B Total (dollars in millions, shares in thousands, except per share data) Basic net income (loss) per share: Numerator: Net income (loss), basic $ 15 $ 1 $ 16 $ (77) $ (4) $ (81) Denominator: Weighted-average shares outstanding, basic 162,681 7,536 170,217 157,081 7,300 164,381 Net income (loss) per share, basic $ 0.09 $ 0.09 $ 0.09 $ (0.49) $ (0.49) $ (0.49) Diluted net income (loss) per share: Numerator: Net income (loss) $ 15 $ 1 $ 16 $ (77) $ (4) $ (81) Gain on extinguishment of debt, net of interest expense 1 (15) (1) (16) — — $ — Net income (loss), diluted $ — $ — $ — $ (77) $ (4) $ (81) Denominator: Number of shares used in basic calculation 162,681 7,536 170,217 157,081 7,300 164,381 Weighted-average effect of diluted securities related to: Convertible senior notes 456 — 456 — — — Number of shares used in diluted calculation 163,137 7,536 170,673 157,081 7,300 164,381 Net income (loss) per share, diluted $ 0.00 $ 0.00 $ 0.00 $ (0.49) $ (0.49) $ (0.49) 1 Under the if-converted method, net income is adjusted to reflect the assumption that the convertible senior notes were converted at the beginning of the period. Nine Months Ended 2024 2023 Class A Class B Total Class A Class B Total (dollars in millions, shares in thousands, except per share data) Basic net income (loss) per share: Numerator: Net income (loss), basic $ 5 $ — $ 5 $ (297) $ (14) $ (311) Denominator: Weighted-average shares outstanding, basic 161,398 7,377 168,775 155,536 7,300 162,836 Net income (loss) per share, basic $ 0.03 $ 0.03 $ 0.03 $ (1.91) $ (1.91) $ (1.91) Diluted net income (loss) per share: Numerator: Net income (loss) $ 5 $ — $ 5 $ (297) $ (14) $ (311) Gain on extinguishment of debt, net of interest expense 1 (17) (1) (18) — — $ — Net income (loss), diluted $ (12) $ (1) $ (13) $ (297) $ (14) $ (311) Denominator: Number of shares used in basic calculation 161,398 7,377 168,775 155,536 7,300 162,836 Weighted-average effect of diluted securities related to: Convertible senior notes 993 — 993 — — — Number of shares used in diluted calculation 162,391 7,377 169,768 155,536 7,300 162,836 Net income (loss) per share, diluted $ (0.08) $ (0.08) $ (0.08) $ (1.91) $ (1.91) $ (1.91) 1 Under the if-converted method, net income is adjusted to reflect the assumption that the convertible senior notes were converted at the beginning of the period.
Schedule of Potentially Dilutive Securities Excluded from Diluted Per Share Calculation	Potentially dilutive securities excluded because they would be anti-dilutive were as follows: Three Months Ended Nine Months Ended 2024 2023 2024 2023 (shares in thousands) Employee share-based awards 13,444 16,731 13,444 16,731 Convertible senior notes 4,170 6,102 4,170 6,102 Total 17,614 22,833 17,614 22,833

Overview and Basis of Present_2

Overview and Basis of Presentation (Details)	9 Months Ended
	Oct. 31, 2024 tradingDay
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	1
Number of reportable segments	1

Restructuring and Other Charg_3

Restructuring and Other Charges - Narrative (Details) - 2024 Restructuring Plan $ in Millions	3 Months Ended
	Jan. 31, 2024 USD ($) employee
Restructuring Cost and Reserve [Line Items]
Restructuring cost, number of positions eliminated | employee	400
Restructuring charges | $	$ 24

Restructuring and Other Charg_4

Restructuring and Other Charges - Schedule of Restructuring Reserve (Details) - Severance and termination benefit costs $ in Millions	9 Months Ended
	Oct. 31, 2024 USD ($)
Restructuring Reserve [Roll Forward]
Beginning balance	$ 24
Restructuring charges	0
Cash payments	(24)
Ending balance	$ 0

Cash Equivalents and Investme_3

Cash Equivalents and Investments - Schedule of Amortized Costs, Unrealized Gains and Losses and Estimated Fair Value of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Cash and Cash Equivalents [Line Items]
Amortized Cost	$ 2,120	$ 2,017
Unrealized Gain	4	3
Unrealized Loss	(1)	(1)
Estimated Fair Value	2,123	2,019
Cash equivalents:
Cash and Cash Equivalents [Line Items]
Amortized Cost	185	151
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	185	151
Cash equivalents: | Money market funds
Cash and Cash Equivalents [Line Items]
Amortized Cost	162	151
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	162	151
Cash equivalents: | Certificates of deposit
Cash and Cash Equivalents [Line Items]
Amortized Cost	23
Unrealized Gain	0
Unrealized Loss	0
Estimated Fair Value	23
Short-term investments (Available-for-sale):
Cash and Cash Equivalents [Line Items]
Amortized Cost	1,935	1,866
Unrealized Gain	4	3
Unrealized Loss	(1)	(1)
Estimated Fair Value	1,938	1,868
Short-term investments (Available-for-sale): | U.S. treasury securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	1,646	1,782
Unrealized Gain	3	3
Unrealized Loss	(1)	(1)
Estimated Fair Value	1,648	1,784
Short-term investments (Available-for-sale): | Corporate debt securities
Cash and Cash Equivalents [Line Items]
Amortized Cost	254	43
Unrealized Gain	1	0
Unrealized Loss	0	0
Estimated Fair Value	255	43
Short-term investments (Available-for-sale): | Certificates of deposit
Cash and Cash Equivalents [Line Items]
Amortized Cost	35	41
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	$ 35	$ 41

Cash Equivalents and Investme_4

Cash Equivalents and Investments - Schedule of Contractual Maturities of Short-term Investments (Details) - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
Amortized Cost
Amortized Cost	$ 2,120	$ 2,017
Estimated Fair Value
Estimated fair value	2,123	2,019
Short-term investments (Available-for-sale):
Amortized Cost
Due within one year	1,422
Due between one to five years	513
Amortized Cost	1,935	1,866
Estimated Fair Value
Due within one year	1,424
Due between one to five years	514
Estimated fair value	$ 1,938	$ 1,868

Cash Equivalents and Investme_5

Cash Equivalents and Investments - Narrative (Details)	9 Months Ended	12 Months Ended
	Oct. 31, 2024 USD ($) investment	Jan. 31, 2024 USD ($) investment
Investments, Debt and Equity Securities [Abstract]
Interest receivable	$ 22,000,000	$ 20,000,000
Number of short-term investments in unrealized loss positions (in investments) | investment	33	41
Other-than-temporary impairment short term investment	$ 0	$ 0
Strategic investments without a readily determinable fair value	$ 31,000,000	$ 26,000,000

Deferred Commissions (Details)

Deferred Commissions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue from Contract with Customer [Abstract]
Sales commissions capitalized as contract costs	$ 37	$ 37	$ 97	$ 102
Amortization of contract costs	$ 33	$ 27	$ 95	$ 76

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 3,659		$ 3,659
Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized that was included in the contract liability balance	597	$ 519	1,312	$ 1,114
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-11-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue from remaining performance obligations	$ 2,062		$ 2,062
Remaining performance obligation, percentage	56%		56%
Performance obligations expected to be satisfied, expected timing	12 months		12 months

Convertible Senior Notes, Net -

Convertible Senior Notes, Net - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Debt Instrument [Line Items]
Gain on early extinguishment of debt	$ 16	$ 18	$ 19	$ 91
Senior Notes
Debt Instrument [Line Items]
Gain on early extinguishment of debt	16	18	19	91
Senior Notes | 2025 Notes
Debt Instrument [Line Items]
Debt repurchased, principal amount	42		42	508
Repayments of debt	40		40	462
Senior Notes | 2026 Notes
Debt Instrument [Line Items]
Debt repurchased, principal amount	215	150	258	392
Repayments of debt	$ 200	$ 132	$ 240	$ 341

Convertible Senior Notes, Net_2

Convertible Senior Notes, Net - Schedule of Convertible Debt (Details) - Senior Notes - USD ($) $ in Millions	Oct. 31, 2024	Jan. 31, 2024
2025 Notes
Debt Instrument [Line Items]
Principal	$ 510	$ 552
Less: unamortized debt issuance costs	(1)	(3)
Net carrying amount	509	549
2026 Notes
Debt Instrument [Line Items]
Principal	350	608
Less: unamortized debt issuance costs	(1)	(3)
Net carrying amount	$ 349	$ 605

Convertible Senior Notes, Net_3

Convertible Senior Notes, Net - Schedule of Carrying Amounts and Estimated Fair Values of Convertible Note (Details) - Senior Notes $ in Millions	Oct. 31, 2024 USD ($)
2025 Notes | Principal Amount
Debt Instrument [Line Items]
Convertible senior notes	$ 510
2025 Notes | Estimated Fair Value
Debt Instrument [Line Items]
Convertible senior notes	486
2026 Notes | Principal Amount
Debt Instrument [Line Items]
Convertible senior notes	350
2026 Notes | Estimated Fair Value
Debt Instrument [Line Items]
Convertible senior notes	$ 324

Commitments and Contingencies (

Commitments and Contingencies (Details)		1 Months Ended
	May 28, 2024 USD ($)	Dec. 13, 2022 plaintiff	Oct. 31, 2024 USD ($)	Jan. 31, 2024 USD ($)
Securities Litigation
Other Commitments [Line Items]
Litigation settlement, amount awarded to other party	$ 60,000,000
Retention amount	$ 10,000,000
Loss contingency liability			$ 60,000,000
Derivative Lawsuit
Other Commitments [Line Items]
Number of plaintiffs | plaintiff		2
Letter of Credit
Other Commitments [Line Items]
Letters of credit issued and outstanding			7,000,000	$ 7,000,000
Draws on line of credit			$ 0

Employee Incentive Plans - Sche

Employee Incentive Plans - Schedule of Stock-based Compensation Expense by Statement of Operations Location (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 135	$ 172	$ 434	$ 523
Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	20	20	61	57
Professional services and other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	3	3	9	11
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	49	70	168	212
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	33	40	99	119
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 30	$ 39	$ 97	$ 124

Employee Incentive Plans - Sc_2

Employee Incentive Plans - Schedule of Unrecognized Stock-based Compensation Expense (Details) $ in Millions	9 Months Ended
	Oct. 31, 2024 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, stock option	$ 2
Total	844
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 813
Weighted-average remaining period (in years)	2 years
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 16
Weighted-average remaining period (in years)	2 years 4 months 24 days
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average remaining period (in years)	3 months 18 days
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 13
Weighted-average remaining period (in years)	7 months 6 days

Employee Incentive Plans - Narr

Employee Incentive Plans - Narrative (Details) - Market-Based RSUs	1 Months Ended
	Mar. 31, 2024 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares granted in period | shares	183,595
Award vesting period	3 years
Granted (in dollars per share) | $ / shares	$ 182.15
Performance Period One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage earned by employees after each completed year of service	33%
Performance Period Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage earned by employees after each completed year of service	33%
Performance Period Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage earned by employees after each completed year of service	33%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	0%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Earn rate, percent of shares granted	200%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 9	$ 7	$ 10	$ 18
Pretax income (loss)	$ 25	$ (74)	$ 15	$ (293)
Effective income tax rate	40.40%	(9.00%)	69.60%	(6.00%)

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Numerator:
Net income (loss), basic	$ 16	$ (81)	$ 5	$ (311)
Denominator:
Weighted-average shares outstanding, basic (in shares)	170,217	164,381	168,775	162,836
Net income (loss) per share, basic (in dollars per share)	$ 0.09	$ (0.49)	$ 0.03	$ (1.91)
Numerator:
Net income (loss), basic	$ 16	$ (81)	$ 5	$ (311)
Gain on extinguishment of debt, net of interest expense	(16)	0	(18)	0
Net income (loss), diluted	$ 0	$ (81)	$ (13)	$ (311)
Denominator:
Weighted-average shares outstanding, basic (in shares)	170,217	164,381	168,775	162,836
Weighted-average effect of diluted securities related to:
Convertible senior notes (in shares)	456	0	993	0
Number of shares used in diluted calculation	170,673	164,381	169,768	162,836
Net income (loss) per share, diluted (in dollars per share)	$ 0	$ (0.49)	$ (0.08)	$ (1.91)
Class A
Numerator:
Net income (loss), basic	$ 15	$ (77)	$ 5	$ (297)
Denominator:
Weighted-average shares outstanding, basic (in shares)	162,681	157,081	161,398	155,536
Net income (loss) per share, basic (in dollars per share)	$ 0.09	$ (0.49)	$ 0.03	$ (1.91)
Numerator:
Net income (loss), basic	$ 15	$ (77)	$ 5	$ (297)
Gain on extinguishment of debt, net of interest expense	(15)	0	(17)	0
Net income (loss), diluted	$ 0	$ (77)	$ (12)	$ (297)
Denominator:
Weighted-average shares outstanding, basic (in shares)	162,681	157,081	161,398	155,536
Weighted-average effect of diluted securities related to:
Convertible senior notes (in shares)	456	0	993	0
Number of shares used in diluted calculation	163,137	157,081	162,391	155,536
Net income (loss) per share, diluted (in dollars per share)	$ 0	$ (0.49)	$ (0.08)	$ (1.91)
Class B
Numerator:
Net income (loss), basic	$ 1	$ (4)	$ 0	$ (14)
Denominator:
Weighted-average shares outstanding, basic (in shares)	7,536	7,300	7,377	7,300
Net income (loss) per share, basic (in dollars per share)	$ 0.09	$ (0.49)	$ 0.03	$ (1.91)
Numerator:
Net income (loss), basic	$ 1	$ (4)	$ 0	$ (14)
Gain on extinguishment of debt, net of interest expense	(1)	0	(1)	0
Net income (loss), diluted	$ 0	$ (4)	$ (1)	$ (14)
Denominator:
Weighted-average shares outstanding, basic (in shares)	7,536	7,300	7,377	7,300
Weighted-average effect of diluted securities related to:
Convertible senior notes (in shares)	0	0	0	0
Number of shares used in diluted calculation	7,536	7,300	7,377	7,300
Net income (loss) per share, diluted (in dollars per share)	$ 0	$ (0.49)	$ (0.08)	$ (1.91)

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023	Oct. 31, 2024	Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	17,614	22,833	17,614	22,833
Employee share-based awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	13,444	16,731	13,444	16,731
Convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,170	6,102	4,170	6,102

Business Combinations (Details)

Business Combinations (Details) - USD ($)	Feb. 01, 2024	Oct. 31, 2024	Jan. 31, 2024
Business Acquisition [Line Items]
Goodwill		$ 5,448,000,000	$ 5,406,000,000
Spera Cybersecurity
Business Acquisition [Line Items]
Consideration transferred	$ 58,000,000
Consideration transferred, cash held back	$ 12,000,000
Consideration transferred, cash held back, payment period	18 months
Goodwill	$ 42,000,000
Goodwill, expected tax deductible amount	$ 0
Spera Cybersecurity | RSAs
Business Acquisition [Line Items]
Stock issued (in shares)	238,795
Award vesting period	3 years
Fair value, unvested	$ 20,000,000
Spera Cybersecurity | Purchased Developed Technology
Business Acquisition [Line Items]
Intangible assets acquired	$ 18,000,000
Useful life of acquired intangible assets	5 years